Price $85.74 |
Market Cap
120.56B
|
Sector Health Care |
Div. Growth
13.20%
|
|
P/E
30.6
|
P/B
2.42
|
P/S
4.09
|
Dividend %
2.10%
|
|
P/CF
58.7
|
P/FCF
37.9
|
Op. Cash Flow
6.88M
|
FCF
2.3
|
|
Op. Margin
17.90%
|
Net Margin
13.60%
|
ROE
8.00%
|
ROI
5.70%
|
|
ROA
4.10%
|
EPS Growth
16.30%
|
Current Ratio
1.7
|
Debt/Equity
51.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.27 | - | - | 91.5M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $3.40 | - | - | 30.8M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.45 | - | - | 4M | Strong Buy |
| Birner Dental Mgmt Services In (BDMS) | $12.25 | - | 6.50% | 25.1M | Strong Buy |
| Momenta Pharmaceuticals, Inc. (MNTA) | $16.75 | - | - | 1.27B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
